Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Effects of naltrexone on lipopolysaccharide-induced sepsis in rats
Shinn Long Lin
, Yen Mei Lee
, Hsin Yi Chang
,
Yu Wen Cheng
, Mao Hsiung Yen
Department of Pharmaceutical Sciences
Ph.D. Program in Drug Discovery and Development Industry
TMU Research Center of Drug Discovery
TMU Research Center of Cell Therapy and Regeneration Medicine
TMU Research Center of Neuroscience
Ph. D. Program in the Clinical Drug Development of Herbal Medicine
Master Program in Clinical Genomics and Proteomics
Department of Ophthalmology
Research output
:
Contribution to journal
›
Article
›
peer-review
23
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effects of naltrexone on lipopolysaccharide-induced sepsis in rats'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Lipopolysaccharide-Induced Sepsis
100%
Naltrexone
100%
Sepsis
18%
Tumor Necrosis Factor
18%
κ-Opioid Receptor
18%
Superoxide
18%
In Vitro
9%
Ischemia
9%
Hypotension
9%
Liver Function
9%
Vascular Bundle
9%
Antiinflammatory Activity
9%
Vasodilatation
9%
Neutrophil
9%
Noradrenalin
9%
Vasoconstriction
9%
Alanine Aminotransferase
9%
Aspartate Aminotransferase
9%
Nitrite
9%
Liver Dysfunction
9%
Opiate Antagonist
9%
Lipopolysaccharide-Induced Septic Shock
9%
Brain Homogenate
9%
Metabolite
9%
Lipid Peroxidation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lipopolysaccharide-Induced Sepsis
100%
Naltrexone
100%
Superoxide
18%
Tumor Necrosis Factor
18%
Opiate Receptor
18%
Sepsis
18%
Ischemia
9%
Mouse
9%
Aspartate Aminotransferase
9%
Nitrite
9%
Alanine Aminotransferase
9%
Antiinflammatory Activity
9%
Hypotension
9%
Noradrenalin
9%
Liver Dysfunction
9%
Opioid Antagonist
9%
Lipopolysaccharide-Induced Septic Shock
9%
Neuroscience
Lipopolysaccharide
100%
Naltrexone
100%
δ -Opioid Receptor
18%
In Vitro
9%
Alanine Aminotransferase
9%
Aspartate Aminotransferase
9%
Anti-Inflammatory
9%
Norepinephrine
9%
Neutrophil Granulocyte
9%
Lipid Peroxidation
9%
Opioid Antagonist
9%